急性复杂性B型主动脉夹层腔内修复五年结局
这项前瞻性非随机Dissection试验评估Valiant Captivia胸主动脉覆膜支架治疗急性复杂性B型主动脉夹层的5年结局。50例患者中86%存在灌注不良、20%破裂,5年免于夹层相关死亡、夹层相关二次手术及内漏分别为83%、86%、85%,主动脉重塑指标持续良好。
要点
- 5年免于夹层相关死亡、二次手术和内漏分别为83%、86%、85%。
- 89%患者支架段假腔完全血栓化,94%真腔直径稳定或增大。
- 随访依从性仅78%,长期结论需谨慎解读。
核心结论
- Valiant Captivia胸主动脉覆膜支架在急性复杂性B型主动脉夹层患者中实现积极且持续的主动脉重塑,长期管理有效。
研究设计与样本
- 前瞻性、非随机Dissection试验,50例急性复杂性B型主动脉夹层患者接受Valiant Captivia胸主动脉覆膜支架治疗。
主要发现
- 基线时86%患者(43/50)存在灌注不良,20%(10/50)存在破裂,94%(46/49)为DeBakey IIIB型夹层。
- 5年免于夹层相关死亡、夹层相关二次手术及内漏分别为83%、86%、85%。
- 5年时89%患者(16/18)支架段假腔完全血栓化,94%(16/17)真腔直径稳定或增大,77%(13/17)假腔直径稳定或减小。
临床怎么用
- 对于急性复杂性B型主动脉夹层,Valiant Captivia胸主动脉覆膜支架可作为长期治疗选择,但需注意随访依从性对结果解读的影响。
局限性
- 5年临床与影像随访依从性为78%(18/23),存在随访依从性局限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Thoracic endovascular aortic repair is the standard of care for acute complicated type B aortic dissections, but long-term single-device outcomes are limited. METHODS: Fifty patients were treated with the Valiant Captivia thoracic stent graft (Medtronic Inc, Santa Rosa, Calif) for acute complicated type B aortic dissections in this prospective, nonrandomized Dissection Trial. All-cause mortality, secondary procedures, and serious adverse events were assessed, and a core lab evaluated images for aortic remodeling. RESULTS: Compliance for both clinical and imaging follow-up was 78% (18 out of 23) for the available patients at 5 years. Notable baseline characteristics were 86% of patients (43 out of 50) had malperfusion, 20% (10 out of 50) had ruptures, and 94% (46 out of 49) had DeBakey class IIIB dissections. The 5-year freedom from dissection-related mortality, secondary procedures related to the dissection, and endoleaks was 83%, 86%, and 85%, respectively. After 5 years, 89% of patients (16 out of 18) had a completely thrombosed false lumen in the stented segment of the aorta and the true lumen diameter over the length of stent graft was stable or increased for 94% of patients (16 out of 17) while the false lumen diameter was stable or decreased in 77% (13 out of 17) after 5 years. CONCLUSIONS: In the Dissection Trial, patients experienced positive and sustained measures of aortic remodeling. Survival outcomes, need for secondary procedures, and adverse event rates were consistent with previous thoracic endovascular aortic repair studies. Although limitations exist with the follow-up compliance, the Valiant Captivia thoracic stent graft system was effective in the long-term management of acute complicated type B aortic dissections in this patient population with a challenging condition.
引用
- Bavaria JE, Brinkman WT, Hughes GC, et al. Five-year outcomes of endovascular repair of complicated acute type B aortic dissections. J Thorac Cardiovasc Surg. 2020. PMID: 32654872. doi:10.1016/j.jtcvs.2020.03.162
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。